THE INSTITUTE FOR CANCER RESEARCH
Federal contract awards won by THE INSTITUTE FOR CANCER RESEARCH (UEI FF1XVJMDYVR1), 2016–2024 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
9
awards
3
expiring in 12 months
1
agency
Category award history
4 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: UNIVERSITY OF LIVERPOOL took Department of Health and Human Services 541714 work from THE INSTITUTE FOR CANCER RESEARCH (Nov 17, 2026).
Agencies buying from THE INSTITUTE FOR CANCER RESEARCH
What THE INSTITUTE FOR CANCER RESEARCH has provided
Awards
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Department of Health and Human Services · No current value reported · Jan 25, 2024
COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS
Department of Health and Human Services · $1,038,958 · Jul 10, 2023
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA
Department of Health and Human Services · $1,199,274 · May 3, 2023
TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTION PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS
Department of Health and Human Services · $948,377 · Sep 15, 2022
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION
Department of Health and Human Services · $2,051,148 · Jun 15, 2022
TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER
Department of Health and Human Services · $1,237,620 · May 18, 2022
TASK ORDER: PREVENTING LUNG CANCER BY TARGETING ACTIVATED STAT3
Department of Health and Human Services · $779,932 · Sep 21, 2020
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
Department of Health and Human Services · $890,103 · Jul 25, 2018
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
Department of Health and Human Services · $988,252 · Sep 20, 2016